Phospholine Iodide

Drug Description
font size

Phospholine Iodide®
(echothiophate iodide) for Ophthalmic Solution

DRUG DESCRIPTION

Chemical name: (2-mercaptoethyl) trimethylammonium iodide O,O-diethyl phosphorothioate

Structural formula

Phospholine Iodide®
  (echothiophate iodide for ophthalmic solution)  Structural Formula Illustration

C9H23INO3PS           M.W 383.23

Echothiophate iodide for ophthalmic solution occurs as a white, crystalline, water-soluble, hygroscopic solid having a slight mercaptan-like odor. When freeze-dried in the presence of potassium acetate, the mixture appears as a white amorphous deposit on the walls of the bottle.

Each package contains materials for dispensing 5 mL of eyedrops: (1) bottle containing sterile echothiophate iodide for ophthalmic solution in one of four potencies [1.5 mg (0.03%), 3 mg (0.06%), 6.25 mg (0.125%), or 12.5 mg (0.25%)] as indicated on the label, with 40 mg potassium acetate in each case. Sodium hydroxide or acetic acid may have been incorporated to adjust pH during manufacturing. (2) a 5 mL bottle of sterile diluent containing chlorobutanol (chloral derivative), 0.55%; mannitol, 1.2%; boric acid, 0.06%; and sodium phosphate, 0.026%. (3) sterilized dropper.

Last updated on RxList: 12/9/2008


Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Bookmark this page:

WebMD Daily

Get breaking medical news.

Glaucoma Laser Treatment Glaucoma Laser Treatment
Glaucoma is a sight-stealing condition caused by pressure in the eye. Now patients are finding results through glaucoma laser treatment. See more WebMD Videos »